AdDIT Editorial comment-challenges in medication treatment of renal and cardiovascular diseases and risk factors in adolescents with type 1 diabetes.
作者信息
Ahmadizar Fariba, Maitland-van der Zee Anke H
机构信息
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Ann Transl Med. 2018 May;6(10):193. doi: 10.21037/atm.2018.03.25.
Abstract
摘要
相似文献
1
AdDIT Editorial comment-challenges in medication treatment of renal and cardiovascular diseases and risk factors in adolescents with type 1 diabetes.《糖尿病护理》编辑评论——1型糖尿病青少年肾和心血管疾病药物治疗的挑战及危险因素
Ann Transl Med. 2018 May;6(10):193. doi: 10.21037/atm.2018.03.25.
2
Highly Accurate and Efficient Data-Driven Methods for Genotype Imputation.高度准确且高效的数据驱动方法进行基因型推断。
IEEE/ACM Trans Comput Biol Bioinform. 2019 Jul-Aug;16(4):1107-1116. doi: 10.1109/TCBB.2017.2708701. Epub 2017 May 26.
3
Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):129. doi: 10.1093/ehjcvp/pvx006.
4
Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes: a population-based cohort study.1型糖尿病儿童和青少年的心血管药物使用与心血管疾病：一项基于人群的队列研究。
Pediatr Diabetes. 2016 Sep;17(6):433-40. doi: 10.1111/pedi.12302. Epub 2015 Aug 11.
5
Response to the 'Comment on the editorial by Turner et al. on Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.'.
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):130. doi: 10.1093/ehjcvp/pvx011.
6
Response to comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.对特纳等人就赞纳德等人关于评估治疗糖尿病新药的心血管风险：风险评估与风险规避的社论所做评论的回应
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):131. doi: 10.1093/ehjcvp/pvx012.
7
Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.颈动脉内中膜厚度和颈动脉斑块对 2 型糖尿病患者微血管和大血管并发症发展的预后影响：里约热内卢 2 型糖尿病队列研究。
Cardiovasc Diabetol. 2019 Jan 10;18(1):2. doi: 10.1186/s12933-019-0809-1.
8
Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.超重会改变青少年心血管危险因素与微量白蛋白尿之间的关联。
Pediatrics. 2008 Jan;121(1):37-45. doi: 10.1542/peds.2007-3594.
9
Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma.转移性肾细胞癌靶向治疗背景下心血管不良事件治疗管理的编辑评论
Int J Urol. 2012 Sep;19(9):805. doi: 10.1111/j.1442-2042.2012.03062.x. Epub 2012 May 31.
引用本文的文献
1
Association of ABO blood groups and non-culprit plaque characteristics in acute coronary syndrome: an optical coherence tomography study.急性冠状动脉综合征中ABO血型与非罪犯斑块特征的关联：一项光学相干断层扫描研究
Ann Transl Med. 2020 Aug;8(16):1011. doi: 10.21037/atm-20-5381.
本文引用的文献
1
Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.1 型糖尿病患者白蛋白尿的消退及其与心血管事件和死亡的发生的关系：芬兰糖尿病研究。
Diabetologia. 2018 May;61(5):1203-1211. doi: 10.1007/s00125-018-4564-8. Epub 2018 Feb 8.
2
Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use.1 型糖尿病患儿和青少年高血压和高胆固醇血症的治疗不足：心血管疾病、危险因素和药物使用的发生时间趋势的长期随访。
Br J Clin Pharmacol. 2018 Apr;84(4):776-785. doi: 10.1111/bcp.13482. Epub 2018 Jan 25.
3
Arterial stiffness in childhood: A predictor for later cardiovascular disease?儿童期动脉僵硬度：日后心血管疾病的预测指标？
Eur J Prev Cardiol. 2018 Jan;25(1):100-102. doi: 10.1177/2047487317743046. Epub 2017 Nov 20.
4
Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?1型糖尿病儿童心血管疾病的可改变风险因素：早期干预能否预防未来心血管事件？
Curr Diab Rep. 2017 Nov 3;17(12):134. doi: 10.1007/s11892-017-0968-y.
5
ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.血管紧张素转换酶抑制剂和他汀类药物在 1 型糖尿病青少年中的应用。
N Engl J Med. 2017 Nov 2;377(18):1733-1745. doi: 10.1056/NEJMoa1703518.
6
Proteinuria in Children: Evaluation and Differential Diagnosis.儿童蛋白尿：评估与鉴别诊断
Am Fam Physician. 2017 Feb 15;95(4):248-254.
7
Diabetic kidney disease: world wide difference of prevalence and risk factors.糖尿病肾病：全球患病率及危险因素的差异
J Nephropharmacol. 2015 Oct 9;5(1):49-56. eCollection 2016.
8
Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.1型糖尿病患者的蛋白尿变化与心血管及肾脏结局：糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究（DCCT/EDIC研究）
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1969-1977. doi: 10.2215/CJN.02870316. Epub 2016 Oct 24.
9
Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice.1型糖尿病青少年的依从性：研究与实践中评估的策略及考量因素
Diabetes Manag (Lond). 2015 Nov;5(6):485-498. doi: 10.2217/dmt.15.41.
10
Causes of death in childhood-onset Type 1 diabetes: long-term follow-up.儿童期发病的1型糖尿病的死亡原因：长期随访
Diabet Med. 2017 Jan;34(1):56-63. doi: 10.1111/dme.13114. Epub 2016 Apr 7.
Zotero 插件